Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Molecular Therapy. Nucleic Acids
|
May 17, 2021
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
Jordi Guiteras, Élia Ripoll, Núria Bolaños, et al.
Frontiers in Pharmacology
|
April 5, 2021
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Pharmaceutics
|
September 27, 2025
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study
Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, et al.
Frontiers in Immunology
|
March 29, 2021
Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
Maria Meneghini, Elena Crespo, Matthias Niemann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 18, 2024
Identification of the atypical antipsychotic Asenapine as a direct survivin inhibitor with anticancer properties and sensitizing effects to conventional therapies
Cristina Benítez-García, David Martínez-García, Martin Kotev, et al.
Kidney International
|
June 30, 2023
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
Nuria Lloberas, Josep M Grinyó, Helena Colom, et al.
Pharmaceutics
|
May 27, 2023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
Pere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, et al.
Therapeutic Drug Monitoring
|
December 8, 2025
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation
Anna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, et al.
Clinical Pharmacology and Therapeutics
|
February 24, 2021
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Frontiers in Immunology
|
July 14, 2022
Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation
Elena Crespo, Anna Vidal-Alabró, Thomas Jouve, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Molecular Therapy. Nucleic Acids
|
May 17, 2021
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
Jordi Guiteras, Élia Ripoll, Núria Bolaños, et al.
Frontiers in Pharmacology
|
April 5, 2021
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Pharmaceutics
|
September 27, 2025
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study
Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, et al.
Frontiers in Immunology
|
March 29, 2021
Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation
Maria Meneghini, Elena Crespo, Matthias Niemann, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 18, 2024
Identification of the atypical antipsychotic Asenapine as a direct survivin inhibitor with anticancer properties and sensitizing effects to conventional therapies
Cristina Benítez-García, David Martínez-García, Martin Kotev, et al.
Kidney International
|
June 30, 2023
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
Nuria Lloberas, Josep M Grinyó, Helena Colom, et al.
Pharmaceutics
|
May 27, 2023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
Pere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, et al.
Therapeutic Drug Monitoring
|
December 8, 2025
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation
Anna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, et al.
Clinical Pharmacology and Therapeutics
|
February 24, 2021
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Frontiers in Immunology
|
July 14, 2022
Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation
Elena Crespo, Anna Vidal-Alabró, Thomas Jouve, et al.
Page
of 3